Clinical Trials List
Protocol NumberA-BR-108-087
Active
2022-06-16 - 2026-12-31
Phase I
Recruiting1
ICD-10C23
Malignant neoplasm of gallbladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9156.0
Malignant neoplasm of gallbladder
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yan-Shen Shan Division of General Surgery
- 蔡弘文 Division of Others
- Yu-Min Yeh Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- 李安富 Division of General Internal Medicine
- Li-Tzong Chen Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Chien-Jui Huang Division of General Internal Medicine
- 趙盈瑞 Division of General Surgery
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
0 participants
